The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter 
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Glossary Glossary

Epzicom (Abacavir/3TC, Kivexa)

The Details

Epzicom (abacavir/lamivudine or ABC/3TC) is a nucleoside reverse transcriptase inhibitor used to treat HIV/AIDS. It is approved by the U.S. FDA for the treatment of HIV infection in adults. It is listed in the HHS HIV treatment guidelines as part of an alternative regimen for people starting HIV treatment for the first time, when taken in combination with Tivicay.


Adult single dose: Take one tablet once daily. Each tablet contains 600 mg of abacavir and 300 mg of lamivudine.


  • Contraindicated in cases of previously demonstrated hypersensitivity to Ziagen or any other component of Epzicom.
  • Contraindicated in cases of hepatic impairment.
  • Epzicom should not be administered with other Epivir- or Retrovir-containing products or Emtriva-containing products.
  • Women should not breastfeed while on Epzicom.

Frequently Asked Questions

  • Email Email
  • Glossary Glossary

The content on this page is free of advertiser influence and was produced by our editorial team. See our advertising policy.